Postmenopausal Women Clinical Trials

6 recruitingLast updated: May 5, 2026

Postmenopausal Women Trials at a Glance

11 actively recruiting trials for postmenopausal women are listed on ClinicalTrialsFinder across 6 cities in 8 countries. The largest study group is Not Applicable with 3 trials, with the heaviest enrollment activity in Beijing, Chengdu, and Guizhou. Lead sponsors running postmenopausal women studies include ImmuneOnco Biopharmaceuticals (Shanghai) Inc., Kashiv BioSciences, LLC, and Department of Endocrinology, St Vincent's Hospital.

Browse postmenopausal women trials by phase

Treatments under study

About Postmenopausal Women Clinical Trials

Looking for clinical trials for Postmenopausal Women? There are currently 6 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Postmenopausal Women trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Postmenopausal Women clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 111 of 11 trials

Recruiting
Not Applicable

Acute Impact of Whey Protein-enriched Milk Fat Globule Membrane Supplementation on Postprandial Markers of Heart and Brain Health

Cardiovascular DiseasesCardiometabolic Risk FactorsCognition+2 more
Loughborough University16 enrolled1 locationNCT06953232
Recruiting

Bone Marrow Fat and Bariatric Surgery-Mediated Bone Loss

Bariatric Surgery in Postmenopausal Women
University Hospital, Lille40 enrolled1 locationNCT05005039
Recruiting
Phase 1

Multiple Ascending Dose Study to Evaluate the Safety, Tolerability and Pharmacokinetics of KSHN001034 in Healthy Postmenopausal Female Volunteers

Healthy Postmenopausal Women
Kashiv BioSciences, LLC40 enrolled2 locationsNCT06995482
Recruiting
Not Applicable

Effects of Lower Body EMS Training in Postmenopausal Women

SarcopeniaPostmenopausal WomenArterial Stiffness, Blood Pressure+1 more
Seoul National University39 enrolled1 locationNCT07385534
Recruiting
Phase 1

A Randomized, Double-blind, Placebo-controlled, Single and Multiple Dose Escalation Phase I Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of IMC-003 for Injection in Healthy Postmenopausal Women

Healthy Postmenopausal Women
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.56 enrolled1 locationNCT07118085
Recruiting
Phase 3

A Comparative Study to Valuating the Efficacy and Safety of QL1206 and Prolia®

Postmenopausal Women With Osteoporosis at High Risk of Fracture
Qilu Pharmaceutical Co., Ltd.278 enrolled1 locationNCT07062978
Recruiting
Phase 3

A Study on Efficacy, Safety and Immunogenicity of 9MW0311 in Postmenopausal Women With Osteoporosis

Postmenopausal Women Osteoporosis
Mabwell (Shanghai) Bioscience Co., Ltd.278 enrolled1 locationNCT06804590
Recruiting
Phase 2

Everolimus and/or Exercise to Prevent Bone Loss in Postmenopausal Women

Postmenopausal Women
Odense University Hospital136 enrolled2 locationsNCT06789900
Recruiting
Not Applicable

Impact of Pomegranate Seed Oil on Postprandial Cardiovascular Disease Risk Markers

Postmenopausal Women
University of Reading15 enrolled1 locationNCT06042673
Recruiting

Screening Triage and Risk Stratification

Cervix CancerHPV TestingPostmenopausal Women
University of Aarhus5,000 enrolled1 locationNCT05727228
Recruiting

Metabolic Effects of SERMs (Selective Oestrogen Receptor Modulators) in healthy men and healthy postmenopausal women

Metabolic effects in healthy men and healthy postmenopausal women
Department of Endocrinology, St Vincent's Hospital24 enrolled1 locationACTRN12607000586415